- Home
- IMAB vs FRPH Comparison
IMAB vs FRPH Comparison
Compare IMAB & FRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMAB
- FRPH
- Stock Information
- Founded
- IMAB 2014
- FRPH 1986
- Country
- IMAB United States
- FRPH United States
- Employees
- IMAB N/A
- FRPH N/A
- Industry
- IMAB Biotechnology: Pharmaceutical Preparations
- FRPH Real Estate
- Sector
- IMAB Health Care
- FRPH Finance
- Exchange
- IMAB Nasdaq
- FRPH Nasdaq
- Market Cap
- IMAB 486.4M
- FRPH 459.4M
- IPO Year
- IMAB 2020
- FRPH N/A
- Fundamental
- Price
- IMAB $4.70
- FRPH $24.53
- Analyst Decision
- IMAB Strong Buy
- FRPH
- Analyst Count
- IMAB 6
- FRPH 0
- Target Price
- IMAB $7.50
- FRPH N/A
- AVG Volume (30 Days)
- IMAB 2.2M
- FRPH 52.3K
- Earning Date
- IMAB 11-14-2025
- FRPH 11-05-2025
- Dividend Yield
- IMAB N/A
- FRPH N/A
- EPS Growth
- IMAB N/A
- FRPH N/A
- EPS
- IMAB N/A
- FRPH 0.28
- Revenue
- IMAB N/A
- FRPH $32,293,999.00
- Revenue This Year
- IMAB N/A
- FRPH N/A
- Revenue Next Year
- IMAB N/A
- FRPH N/A
- P/E Ratio
- IMAB N/A
- FRPH $87.61
- Revenue Growth
- IMAB N/A
- FRPH 3.18
- 52 Week Low
- IMAB $0.60
- FRPH $23.52
- 52 Week High
- IMAB $6.79
- FRPH $33.00
- Technical
- Relative Strength Index (RSI)
- IMAB 49.60
- FRPH 45.88
- Support Level
- IMAB $4.13
- FRPH $24.57
- Resistance Level
- IMAB $6.79
- FRPH $25.55
- Average True Range (ATR)
- IMAB 0.72
- FRPH 0.53
- MACD
- IMAB -0.14
- FRPH 0.07
- Stochastic Oscillator
- IMAB 21.43
- FRPH 44.26
About IMAB I-MAB
I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).
About FRPH FRP Holdings Inc.
FRP Holdings Inc is a holding company engaged in various real estate businesses. The company's business segments are Leasing and management of commercial properties owned by the company (the Industrial/Commercial Segment); Leasing and management of mining royalty land owned by the company (the Mining Royalty Lands Segment); real property acquisition, entitlement, development and construction for apartment, retail, warehouse, and office buildings either alone or through joint ventures (the Development Segment); ownership, leasing and management of buildings through joint ventures (the Multifamily Segment).